SEC Form 4 · accession 0001104659-16-128571
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 2:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.56 | Jun 17, 2016 | A | 17,647 | A | — | Jun 16, 2026 | Common Stock | 17,647 | 17,647 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 17, 2016.